Does FRUQUINTINIB Cause Myelosuppression? 122 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 122 reports of Myelosuppression have been filed in association with FRUQUINTINIB (Fruzaqla). This represents 4.8% of all adverse event reports for FRUQUINTINIB.
122
Reports of Myelosuppression with FRUQUINTINIB
4.8%
of all FRUQUINTINIB reports
1
Deaths
74
Hospitalizations
How Dangerous Is Myelosuppression From FRUQUINTINIB?
Of the 122 reports, 1 (0.8%) resulted in death, 74 (60.7%) required hospitalization.
Is Myelosuppression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FRUQUINTINIB. However, 122 reports have been filed with the FAERS database.
What Other Side Effects Does FRUQUINTINIB Cause?
Death (647)
Fatigue (366)
Colon cancer (277)
Blood pressure increased (223)
Diarrhoea (213)
Colorectal cancer metastatic (212)
Decreased appetite (184)
Asthenia (178)
Dysphonia (176)
Off label use (133)
What Other Drugs Cause Myelosuppression?
CYCLOPHOSPHAMIDE (3,603)
CARBOPLATIN (2,624)
TRASTUZUMAB (2,552)
PACLITAXEL (2,522)
TISLELIZUMAB (2,142)
CYTARABINE (1,869)
VENETOCLAX (1,864)
CISPLATIN (1,849)
BEVACIZUMAB (1,744)
SODIUM (1,696)
Which FRUQUINTINIB Alternatives Have Lower Myelosuppression Risk?
FRUQUINTINIB vs FULVESTRANT
FRUQUINTINIB vs FURAZOLIDONE
FRUQUINTINIB vs FUROSEMIDE
FRUQUINTINIB vs FUROSEMIDE\SPIRONOLACTONE
FRUQUINTINIB vs FUSIDATE